FLSM

Frazier Life Sciences Management Portfolio holdings

AUM $3.72B
1-Year Est. Return 129.71%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+129.71%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.5B
AUM Growth
+$313M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
55
New
Increased
Reduced
Closed

Top Buys

1
+$60.3M
2
+$31.5M
3
+$29.8M
4
EOLS icon
Evolus
EOLS
+$24.9M
5
CYTK icon
Cytokinetics
CYTK
+$19.3M

Top Sells

1
+$36M
2
+$35.7M
3
+$15.7M
4
ACAD icon
Acadia Pharmaceuticals
ACAD
+$7.81M
5
RCKT icon
Rocket Pharmaceuticals
RCKT
+$7.2M

Sector Composition

1 Healthcare 99.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$20M 0.8%
770,000
27
$19.6M 0.78%
+366,784
28
$18.3M 0.73%
+554,731
29
$17.8M 0.71%
4,424,725
+3,469,210
30
$17.8M 0.71%
625,000
+100,000
31
$17.7M 0.71%
+1,772,116
32
$16.3M 0.65%
722,400
+32,388
33
$15.4M 0.62%
474,405
-65,000
34
$14.8M 0.59%
+1,002,092
35
$14.3M 0.57%
1,505,984
+62,643
36
$12.5M 0.5%
1,734,601
+798,025
37
$12.1M 0.48%
384,782
+83,612
38
$10.8M 0.43%
1,065,334
-344,859
39
$10.5M 0.42%
4,623,324
40
$8.24M 0.33%
+1,458,333
41
$7.32M 0.29%
+453,685
42
$6.58M 0.26%
1,953,547
43
$6.54M 0.26%
583,327
44
$5.63M 0.23%
970,130
-178,461
45
$4.37M 0.17%
3,868,750
46
$4M 0.16%
500,333
47
$3.84M 0.15%
3,175,665
48
$2.3M 0.09%
1,069,244
49
$2.2M 0.09%
5,993,579
50
– –
-470,338
1
2
3